0 results available. Select is focused ,type to refine list, press Down to open the menu,
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company’s lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides c...
The following section summarizes insights on Nutriband Inc's EV / EBITDA Growth Ratio:
We've identified the following companies as similar to Nutriband Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EV / EBITDA Growth Ratio in the valuation category include:
A heuristic used to measure the level of EBITDA growth relative to the EV / EBITDA multiple.
The chart above depicts the distribution of ev / ebitda growth ratio for companies operating in the Healthcare sector in the Developed economic region. Over 600 companies were considered in this analysis, and 584 had meaningful values. The average ev / ebitda growth ratio of companies in the sector is 1.2 with a standard deviation of 2.2.
Nutriband Inc's EV / EBITDA Growth Ratio of NM- ranks in the - percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 608 |
| Included Constituents | 584 |
| Min | 0.0 |
| Max | 19.6 |
| Median | 0.4 |
| Mean | 1.2 |
| Standard Deviation | 2.2 |
You can find companies with similar ev / ebitda growth ratio using this stock screener.